NDR Review: A Year of Steady Progress
On November 19, Analyst Won-seok Jung from Shinyoung Securities published a research report on EMRO.
Analyst Won-seok Jung evaluated that while EMRO's short-term financial performance was somewhat disappointing, the company has established a solid foundation for global expansion based on international certifications and reference cases. He projected that the prolongation of Proof of Concept (PoC) processes—the key driver behind delayed overseas revenue—will gradually improve, analyzing that the functional enhancements of Caidentia will lead to mid- to long-term leverage effects. Furthermore, Analyst Jung maintained a 'BUY' rating and a target price of 50,000 KRW, citing the expansion of North American and European client bases as well as the monetization of Agentic AI as positive factors.
For more details, please refer to the attached report.
NDR Review: A Year of Steady Preparation
▶ Short-term financial results remain subdued, but a solid groundwork for global expansion has been established based on international certifications and reference cases.
▶ The primary factor behind delayed overseas performance stems from the prolonged Proof of Concept (PoC) duration with international clients.
▶ Target price maintained at 50,000 KRW.